Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Laboratory Corp of America (LH)  
$199.45 2.48 (1.23%) as of 4:30 Thu 4/18


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 97,400,000
Market Cap: 19.43(B)
Last Volume: 768,904 Avg Vol: 761,345
52 Week Range: $197.69 - $241.33
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  274
Guru Rank Value     : 4.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Laboratory Corporation of America Holdings is a life sciences company that provides information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make decisions. Co. reports its business in two segments, LabCorp Diagnostics (Dx) and Labcorp Drug Development (DD). Dx is an independent clinical laboratory business. It provides a menu of requested and specialty testing through a network of primary and specialty laboratories across the U.S. DD provides drug development, medical device and diagnostic development solutions from early-stage research to clinical development and commercial market access.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 44
Total Buy Value $0 $0 $0 $10,251
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 54,498 55,882 66,894 137,120
Total Sell Value $11,803,667 $12,095,294 $14,461,869 $31,164,181
Total People Sold 5 6 8 8
Total Sell Transactions 10 11 15 25
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 933
  Page 1 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Eisenberg Glenn A Chief Financial Officer, EVP   •       •      –    2024-04-15 4 D $203.32 $914,127 D/D (4,496) 40,556     -
   Eisenberg Glenn A Chief Financial Officer, EVP   •       •      –    2024-04-15 4 OE $0.00 $0 D/D 10,229 45,052     -
   Bailey Megan D. EVP, Chief Strategy Officer   •       •      –    2024-04-01 4 D $216.35 $14,928 D/D (69) 436     -
   Bailey Megan D. EVP, Chief Strategy Officer   •       •      –    2024-04-01 4 OE $0.00 $0 D/D 205 505     -
   Summy Amy B. EVP, Chief Marketing Officer   •       •      –    2024-04-01 4 AS $217.29 $760,515 D/D (3,500) 3,975 -5%     
   Schroeder Mark S EVP, Pres Diagnostics & COO   •       •      –    2024-04-01 4 AS $217.29 $1,407,387 D/D (6,477) 5,036 -5%     
   Van Der Vaart Sandra D EVP, Chief Legal Officer   •       –      –    2024-03-28 4 AS $216.74 $770,077 D/D (3,553) 7,637 -6%     
   Eisenberg Glenn A Chief Financial Officer, EVP   •       –      –    2024-03-27 4 D $216.57 $1,906,899 D/D (8,805) 34,823     -
   Eisenberg Glenn A Chief Financial Officer, EVP   •       –      –    2024-03-27 4 OE $0.00 $0 D/D 20,033 43,628     -
   Wilkinson Peter J SVP, Chief Accounting Officer   •       –      –    2024-03-27 4 D $216.57 $193,614 D/D (894) 4,526     -
   Wilkinson Peter J SVP, Chief Accounting Officer   •       –      –    2024-03-27 4 OE $0.00 $0 D/D 3,079 5,420     -
   Schroeder Mark S EVP, Pres Diagnostics & COO   •       –      –    2024-03-27 4 D $216.57 $1,099,959 D/D (5,079) 11,513     -
   Schroeder Mark S EVP, Pres Diagnostics & COO   •       –      –    2024-03-27 4 OE $0.00 $0 D/D 11,556 16,592     -
   Van Der Vaart Sandra D EVP, Chief Legal Officer   •       –      –    2024-03-27 4 D $216.57 $564,165 D/D (2,605) 11,190     -
   Van Der Vaart Sandra D EVP, Chief Legal Officer   •       –      –    2024-03-27 4 OE $0.00 $0 D/D 6,158 13,795     -
   Schechter Adam H President and CEO   •       •      –    2024-03-27 4 D $216.57 $6,886,709 D/D (31,799) 93,630     -
   Schechter Adam H President and CEO   •       •      –    2024-03-27 4 OE $0.00 $0 D/D 72,435 125,429     -
   Berberian Lance EVP, CIO & CTO   •       –      –    2024-03-27 4 D $216.57 $714,464 D/D (3,299) 28,014     -
   Berberian Lance EVP, CIO & CTO   •       –      –    2024-03-27 4 OE $0.00 $0 D/D 7,697 31,313     -
   Caveney Brian J EVP, Pres of ED, CMO & CSO   •       –      –    2024-03-27 4 D $216.57 $1,096,061 D/D (5,061) 27,881     -
   Caveney Brian J EVP, Pres of ED, CMO & CSO   •       –      –    2024-03-27 4 OE $0.00 $0 D/D 11,556 32,942     -
   Divincenzo Jonathan EVP, Pres, Central Labs & Intl   •       –      –    2024-03-27 4 D $216.57 $206,175 D/D (952) 5,461     -
   Divincenzo Jonathan EVP, Pres, Central Labs & Intl   •       –      –    2024-03-27 4 OE $0.00 $0 D/D 3,012 6,413     -
   Summy Amy B. EVP, Chief Marketing Officer   •       –      –    2024-03-27 4 D $216.57 $468,224 D/D (2,162) 7,475     -
   Summy Amy B. EVP, Chief Marketing Officer   •       –      –    2024-03-27 4 OE $0.00 $0 D/D 5,778 9,637     -

  933 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed